CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −7,822 | $8.98 | $70K | 5,500,730 |
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Sale | −75 | $8.98 | $674 | 49,270 |
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −6,057 | 0 | ||
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −58 | 0 | ||
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −1,765 | 0 | ||
| 2018-02-13 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −17 | 0 | ||
| 2018-01-25 | KIRITSY CHRISTOPHER P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-25 | ADAMS JULIAN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-25 | BIZZARI JEAN-PIERRE Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +2,243 | $5.09 | $11K | 2,243 |
| 2018-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-25 | Prelack Steven Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-01-25 | GERAGHTY JAMES A Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-01-03 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,693,492 | $7.35 | $12.4M | 5,500,730 |
| 2018-01-03 | ORBIMED ADVISORS LLC 10% owner | Sale | −16,128 | $7.35 | $119K | 49,270 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +27,241 | $2.00 | $54K | 7,221,463 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +259 | $2.00 | $518 | 65,657 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +5,227 | $3.00 | $16K | 7,226,690 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +50 | $3.00 | $150 | 65,707 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +6,654 | $2.62 | $17K | 7,233,344 |
Page 16 of 21 · 412 trades